Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease

Table 1 Clinical and laboratory data of patients with NAFLD and controls

	NAFLD	Control	P
n	30	30
Gender (F/M)	15/15	16/14	0.8
Age	41.97 ± 8.36	43.90 ± 8.35	0.374
BMI (kg/m2)	26.47 ± 3.11	23.97 ± 1.88	< 0.001
Total cholesterol (mmol/L)	4.11 ± 0.85	3.97 ± 0.63	0.446
Triglyceride (mmol/L)	1.54 ± 0.62	1.30 ± 0.38	0.075
C-peptide (nmol/L)	1.73 ± 0.29	1.78 ± 0.34	0.505
Glucose (mmol/L)	5.42 ± 0.94	5.03 ± 0.68	0.072
Insulin (mU/L)	14.22 ± 2.66	8.64 ± 1.88	< 0.001
HOMA IR	3.46 ± 1.04	1.92 ± 0.45	< 0.001
Leptin (ng/mL)	10.90 ± 3.39	5.55 ± 1.96	< 0.001
sOB-R (ng/mL)	18.00 ± 3.74	23.51 ± 2.62	< 0.001